Search Page

1

Cite

Share

On the origin of cancer metastasis.

Seyfried TN, Huysentruyt LC. Seyfried TN, et al. Crit Rev Oncog. 2013;18(1-2):43-73. doi: 10.1615/critrevoncog.v18.i1-2.40. Crit Rev Oncog. 2013. PMID: 23237552 Free PMC article. Review.

Cite

Share

2

Cite

Share

Meal frequency and timing in health and disease.

Mattson MP, Allison DB, Fontana L, Harvie M, Longo VD, Malaisse WJ, Mosley M, Notterpek L, Ravussin E, Scheer FA, Seyfried TN, Varady KA, Panda S. Mattson MP, et al. Among authors: seyfried tn. Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16647-53. doi: 10.1073/pnas.1413965111. Epub 2014 Nov 17. Proc Natl Acad Sci U S A. 2014. PMID: 25404320 Free PMC article.

Cite

Share

3

Cite

Share

Metabolic therapy: a new paradigm for managing malignant brain cancer.

Seyfried TN, Flores R, Poff AM, D'Agostino DP, Mukherjee P. Seyfried TN, et al. Cancer Lett. 2015 Jan 28;356(2 Pt A):289-300. doi: 10.1016/j.canlet.2014.07.015. Epub 2014 Jul 25. Cancer Lett. 2015. PMID: 25069036 Review.

Cite

Share

4

Cite

Share

Consideration of Ketogenic Metabolic Therapy as a Complementary or Alternative Approach for Managing Breast Cancer.

Seyfried TN, Mukherjee P, Iyikesici MS, Slocum A, Kalamian M, Spinosa JP, Chinopoulos C. Seyfried TN, et al. Front Nutr. 2020 Mar 11;7:21. doi: 10.3389/fnut.2020.00021. eCollection 2020. Front Nutr. 2020. PMID: 32219096 Free PMC article. Review.

Cite

Share

5

Cite

Share

Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?

Seyfried TN, Shelton L, Arismendi-Morillo G, Kalamian M, Elsakka A, Maroon J, Mukherjee P. Seyfried TN, et al. Neurochem Res. 2019 Oct;44(10):2392-2404. doi: 10.1007/s11064-019-02795-4. Epub 2019 Apr 25. Neurochem Res. 2019. PMID: 31025151

Cite

Share

6

Cite

Share

Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma.

Mukherjee P, Augur ZM, Li M, Hill C, Greenwood B, Domin MA, Kondakci G, Narain NR, Kiebish MA, Bronson RT, Arismendi-Morillo G, Chinopoulos C, Seyfried TN. Mukherjee P, et al. Among authors: seyfried tn. Commun Biol. 2019 May 29;2:200. doi: 10.1038/s42003-019-0455-x. eCollection 2019. Commun Biol. 2019. PMID: 31149644 Free PMC article.

Cite

Share

7

Cite

Share

Effects of Ketogenic metabolic therapy on patients with breast cancer: A randomized controlled clinical trial.

Khodabakhshi A, Akbari ME, Mirzaei HR, Seyfried TN, Kalamian M, Davoodi SH. Khodabakhshi A, et al. Among authors: seyfried tn. Clin Nutr. 2020 Jul 3:S0261-5614(20)30339-3. doi: 10.1016/j.clnu.2020.06.028. Online ahead of print. Clin Nutr. 2020. PMID: 32703721

Cite

Share

8

Cite

Share

Management of Glioblastoma Multiforme in a Patient Treated With Ketogenic Metabolic Therapy and Modified Standard of Care: A 24-Month Follow-Up.

Elsakka AMA, Bary MA, Abdelzaher E, Elnaggar M, Kalamian M, Mukherjee P, Seyfried TN. Elsakka AMA, et al. Among authors: seyfried tn. Front Nutr. 2018 Mar 29;5:20. doi: 10.3389/fnut.2018.00020. eCollection 2018. Front Nutr. 2018. PMID: 29651419 Free PMC article.

Cite

Share

9

Cite

Share

On the Origin of ATP Synthesis in Cancer.

Seyfried TN, Arismendi-Morillo G, Mukherjee P, Chinopoulos C. Seyfried TN, et al. iScience. 2020 Nov 2;23(11):101761. doi: 10.1016/j.isci.2020.101761. eCollection 2020 Nov 20. iScience. 2020. PMID: 33251492 Free PMC article. Review.

Cite

Share

10

Cite

Share

Ceruloplasmin gene defect associated with epilepsy in EL mice.

Garey CE, Schwarzman AL, Rise ML, Seyfried TN. Garey CE, et al. Among authors: seyfried tn. Nat Genet. 1995 Sep;11(1):104. doi: 10.1038/ng0995-104f. Nat Genet. 1995. PMID: 7550304 No abstract available.

Cite

Share